Nucleus accumbens dopamine and the forebrain circuitry involved in behavioral activation and effort-related decision making: Implications for understanding anergia and psychomotor slowing in depression

Current Psychiatry Reviews

Volumn 2, Issue 2, 2006, Pages 267-280

  Salamone, John D ^a   Correa, Mercè ^a,b   Mingote, Susana M ^a   Weber, Suzanne M ^a   Farrar, Andrew M ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITAT JAUME I   (Spain)

Author keywords

Brain activity; Dopamine transmission; Fixed ratio 1 (FR1); Molar programmed reinforcement densities; Motor functions

Indexed keywords

8 BROMO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALCOHOL; AMFEBUTAMONE; AMPHETAMINE; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BROMOCRIPTINE; CENTRAL STIMULANT AGENT; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FENFLURAMINE; FLUPENTIXOL; HALOPERIDOL; HYPNOTIC SEDATIVE AGENT; LEVODOPA; METHAMPHETAMINE; RACLOPRIDE;

ANIMAL BEHAVIOR; APATHY; BEHAVIOR DISORDER; BRAIN FUNCTION; CLINICAL PSYCHOLOGY; CLINICAL RESEARCH; DECISION MAKING; DEPRESSION; DOPAMINERGIC SYSTEM; ENERGY; ETHNOLOGY; FATIGUE; FOREBRAIN; FRONTAL CORTEX; HUMAN; MENTAL DISEASE; MOTIVATION; MOTOR ACTIVITY; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SYNTHESIS INHIBITION; PSYCHIATRIST; PSYCHOLOGY; PSYCHOMOTOR DISORDER; PSYCHOMOTOR RETARDATION; RAT; REVIEW; STRIATE CORTEX; TASK PERFORMANCE;

EID: 33745826287     PISSN: 15734005     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340006776875914     Document Type: Review

References (142)

1. Tylee A, Gastpar M, Lepine JP, Mendlewicz J. DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. Int Clin Psychopharmacol 1999; 14: 139-51.
2. Stahl SM. The psychopharmacology of energy and fatigue. J Clin Psychiat 2002; 63: 7-8.
3. Greden JF, Carrol BJ. Decrease in speech pause times with treatment of endogenous depression. Biol Psychiat 1980; 15: 575-87.
4. Greden JF, Albala AA, Smokler IA, Gardner R, Carrol BJ. Speech pause time: A marker of psychomotor retardation among endogenous depressives. Biol Psychiat 1981; 16: 851-9.
5. Willner P. Dopamine and depression: A review of recent evidence. I. Empirical Studies. Brain Res Rev 1983; 6: 211-24.
6. Judge R, Plewes JM, Kumar V, Koke SC, Kopp JB. Changes in energy during treatment of depression: an analysis of floxetine in double-blind, placebo controlled trials. J Clin Psychopharmacol 2000; 20: 666-72.
7. Sabbe B, van Hoof J, Hulstijn W, Zitman F. Changes in fine motor retardation in depressed patients treated with fluoxetine. J Aff Dis 1996; 40: 149-57.
8. Swindle R. Energy and improved workplace productivity in depression. In: Investing in Health: The Social and Economic Benefits of Health Care Innovation vol 14. Elsevier Science 2001; pp 323-41.
9. Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trend Pharmacol Sci 2002; 23: 238-45.
10. Moos RH, Cronkite RC. Symptom-based predictors of a 10-yr chronic course of treated depression. J Nerv Ment Dis 1999; 187: 360-8.
11. Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiat Scand 2000; 101: 11-20.
12. Kalechstein AD, Newton TF, Leavengood AH. Apathy syndrome in cocaine dependence. Psychiat Res 2002; 109: 97-100.
13. Marin RS, Fogel BS, Hawkins J, Duffy J, Krupp BJ. Apathy: a treatable syndrome.Neuropsychiatry Clin Neurosci 1995; 7:23-30.
14. Campbell JJ, Duffy JD. Treatment strategies in amotivated patients. Psychiat Ann 197; 27: 44-9.
15. Marin RS. Apathy: Concept, Syndrome, Neural Mechanisms, and Treatment. Semin Clin Neuropsychiatry 1996; 1: 304-14.
16. Salamone JD. Complex motor and sensorimotor functions of striatal and accumbens dopamine: Involvement in instrumental behavior processes. Psychopharmacol 1992; 107: 160-74.
17. Salamone JD. Behavioral pharmacology of dopamine systems: A new synthesis. In: Willner, P.; Scheel-Kruger, J. eds., The Mesolimbic Dopamine System: From Motivation to Action. Cambridge, England: Cambridge University Press. 1991; 599-613.
18. Cofer CN, Appley MH. Motivation: Theory and Research. New York: John Wiley and Sons 1964.
19. Duffy E. Activation and Behavior. New York: John Wiley and Sons 1963.
20. Salamone JD. Different effects of haloperidol and extinction on instrumental behaviors. Psychopharmacol 1986; 88: 18-23.
21. Salamone JD. The actions of neuroleptic drugs on appetitive instrumental behaviors. In: Iversen L.L., Iversen S.D. and Snyder S.H., eds., Handbook of Psychopharmacology. NY: Plenum Press. 1987; 19, 575-608.
22. Salamone JD. Dopaminergic involvement in activational aspects of motivation: effects of haloperidol on schedule-induced activity, feeding and foraging in rats. Psychobiol 1988; 16: 196-206.
23. Koob GF, Riley SJ, Smith SC, Robbins TW. Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi and olfactory tubercle on feeding, locomotor activity, and amphetamine anorexia in the rat. J Comp Physiol Psychol 1978; 92:917-927.
24. Koob GF, Swerdlow NR. The functional output of the mesolimbic dopamine system. Ann NY Acad Sci 1988; 537: 216-27.
25. Neill DB, Justice JB. An hypothesis for a behavioral function of dopaminergic transmission in nucleus accumbens. In: Chronister RB, Defrance JF Eds. The Neurobiology of the Nucleus Accumbens. Brunswick, Canada: Huer Institute 1981.
26. Aberman JE, Salamone JD. Nucleus accumbens dopamine depletions make rats more sensitive to high ratio requirements do not affect primary food reinforcement. Neuroscience 1999; 92: 545-52.
27. Salamone JD, Correa M. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav Brain Res 2002; 137: 3-25.
28. Salamone JD, Wisniecki A, Carlson BB, Correa M. Nucleus accumbens dopamine depletions make animals highly sensitive to high fixed ratio requirements but do not impair primary food reinforcement. Neurosci 2001; 105: 863-70.
29. Mingote S, Weber SM, Ishiwari K, Correa M, Salamone JD. Temporal and ratio requirements of operant schedules influence sensitivity to nucleus accumbens dopamine depletions. Euro J Neurosci 2005; 21:1749-1757.
30. Salamone JD, Steinpreis RE, McCullough LD, Smith P, Grebel D, Mahan K. Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase fee food consumption in a novel food-choice procedure. Psychopharmacol 1991; 104: 515-21.
31. Salamone JD, Cousins MS, Snyder BJ. Behavioral functions of nucleus accumbens dopamine: Empirical and conceptual problems with the anhedonia hypothesis. Neurosci Biobehav Rev 1997; 21: 341-59.
32. Salamone JD, Correa M, Mingote S, Weber S. Nucleus accumbens dopamine and the regulation of effort in food-seeking behavior: implications for studies of natural motivation, psychiatry, and drug abuse. J Pharmacol Exp Ther 2003; 305: 1-8.
33. Salamone JD, Correa M, Mingote S, Weber S. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Curr Opin Pharmacol 2005; 5: 34-41.
34. Walton ME, Bannerman DM, Rushworth MFS. The role of medial frontal cortex in effort-related decisions. J Neurosci 2002; 22: 10996-11003.
35. Walton ME, Bannerman DM, Alterescu K, Rushworth MFS. Functional specialization within medial frontal cortex of the anterior cingulated for evaluating effort-related decisions. J Neurosci 2003; 23: 6475-9.
36. Salamone JD, Aberman JE, Sokolowski JD, Cousins MS. Nucleus accumbens dopamine and rate of responding: Neurochemical and behavioral studies. Psychobiol 1999; 27: 236-47.
37. Wise RA. Neuroleptics and operant behavior: the anhedonia hypothesis. Behav Brain Sci 1982; 5: 39-87.
38. Wise RA. Dopamine, learning and motivation. Nat Rev 2004, 5: 1-12.
39. Smith GP. Dopamine and food reward. Prog Psychobiol Physiol Psychol 1995; 16: 83-144.
40. Salamone JD. Involvement of nucleus accumbens dopamine in appetitive and aversive motivation. Behav Brain Res 1994; 61: 117-33.
41. Killcross AS, Everitt BJ, Robbins TW. Symmetrical effects of amphetamine and -flupenthixol on conditioned punishment and conditioned reinforcement; contrasts with midazolam. Psychopharmacol 1997; 129: 141-52.
42. DiChiara G. Nucleus accumbens shell and core dopamine: Differential role in behavior and addiction. Behav Brain Res 2002; 137: 75-114.
43. Huang ACW, Hsiao S. Haloperidol attenuates rewarding and aversively conditioned suppression of saccharin solution intake: Reevaluation of the anhedonia hypothesis of dopamine blocking. Behav Neurosci 2002; 116: 646-650.
44. McCullough LD, Salamone JD. Involvement of nucleus accumbens dopamine in the motor activity induced by periodic food presentation: A microdialysis and behavioral study. Brain Res 1992; 592: 29-36.
45. McCullough LD, Sokolowsi JD, Salamone JD. A neurochemical and behavioral investigation of the involvement of nucleus accumbens dopamine in instrumental avoidance. Neuroscience 1993; 52: 919-25.
46. Salamone JD. The behavioral neurochemistry of motivation: Methodological and conceptual issues in studies of the dynamic activity of nucleus accumbens dopamine. J Neurosci Meth 1996; 64: 137-49.
47. Joseph MH, Datla K, Young AM. The interpretation of the measurement of nucleus accumbens dopamine by in vivo dialysis: the kick, the craving or the cognition? Neurosci Biobehav Rev 2003; 27: 527-41.
48. Smith-Roe SL, Kelley AE. Coincident activation of NMDA and dopamine D1 receptors within the nucleus accumbens core is required for appetitive instrumental learning. J Neurosci 2000; 20: 7737-42.
49. Santi AN, Parker LA. The dopamine antagonist, alpha-flupenthixol, interferes with naloxone-induced place aversion learning, but not with acute opiate dependence in rats. Pharmacol Biochem Behav 2001; 70: 193-7.
50. Schoenbaum G, Setlow B. Lesions of nucleus accumbens disrupt learning about aversive outcomes. J Neurosci 2003; 23: 9833-41.
51. Wise RA, Spindler J, deWit H, Gerber GJ. Neuroleptic-induced "anhedonia" in rats: Pimozide blocks reward quality of food. Science 1978; 201: 262-4.
52. Wise RA, Spindler J, Legult L. Major attenuation of food reward with performance-sparing doses of pimozide in the rat. Can J Psychol 1978; 32: 77-85.
53. Salamone JD, Kurth P, McCullough LD, Sokolowski JD. The effects of nucleus accumbens dopamine depletions on continuously reinforced operant responding: Contrasts with the effects of extinction. Pharmacol Biochem Behav 1995; 50: 437-43.
54. Baldo BA, Sadeghian K, Basso KM, Kelley AE. Effects of selective dopamine D1 or D2 receptor blockade within nucleus accumbens subregions on injestive behavior and associated motor activity. Behav Brain Res 2002; 137: 165-77.
55. Roberts DCS, Corcoran ME, Fibiger HC. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav 1977; 6: 615-20.
56. Caine SB, Koob GF. Effects of mesolimbic dopamine depletion on responding maintained by cocaine and food. J Exp Anal Behav 1994; 61: 213-221.
57. Ungerstedt U. Aphagia and adipsia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand 1971; 82: 95-122.
58. Jicha GA, Salamone JD. Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletions: Possible relation to parkinsonian symptoms. J Neurosci 1991; 11: 3822-9.
59. Salamone JD, Mahan K, Rogers S. Ventrolateral striatal dopamine depletions impair feeding and food handling in rats. Pharmacol Biochem Behav 1993; 44: 605-10.
60. Salamone JD, Kurth PA, McCullough LD, Sokolowski JD, Cousins MS. The role of brain dopamine in response initiation: Effects of haloperidol and regionally-specific dopamine depletions on the local rate of instrumental responding. Brain Res 1993; 628: 218-26.
61. Kelley AE. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci Biobehav Rev 2004; 27: 765-76.
62. Berridge KC, Robinson TE. What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Res Rev 1998; 28: 309-69.
63. Ikemoto S, Panksepp J. Dissociations between appetitive and consummatory responses by pharmacological manipulations of reward-relevant brain regions. Behav Neurosci 1996; 110: 331-45.
64. Ikemoto S, Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Rev 1999; 31: 6-41.
65. Cardinal RN, Parkinson JA, Hall J, Everitt BJ. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 2002; 26: 321-52.
66. Salamone JD, Cousins MS, Bucher S. Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure. Behav Brain Res 1994; 65: 221-9.
67. Robbins TW, Roberts DC, Koob GF. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens. J Pharmacol Exp Ther 1983; 224: 662-73.
68. Cousins MS, Sokolowski JD, Salamone JD. Different effects of nucleus accumbens and ventrolateral striatal dopamine depletions on instrumental response selection in the rat. Pharmacol Biochem Behav 1993; 46: 943-51.
69. Correa M, Carlson BB, Wisniecki A, Salamone JD. Nucleus accumbens dopamine and work requirements on interval schedules. Behav Brain Res 2002; 137: 179-87.
70. McCullough LD, Salamone JD. Anxiogenic drugs beta-CCE and FG 7142 increase extracellular dopamine levels in the nucleus accumbens. Psychopharmacol 1992; 109: 379-82.
71. Cousins MS, Trevitt J, Atherton A, Salamone JD. Different behavioral functions of dopamine in nucleus accumbens and ventrolateral striatum: A microdialysis and behavioral investigation. Neuroscience 1999; 91: 925-34.
72. Sokolowski JD, Salamone JD. The role of nucleus accumbens dopamine in lever pressing and response allocation: Effects of 6-OHDA injected into core and dorsomedial shell. Pharmacol Biochem Behav 1998; 59: 557-66.
73. Ishiwari K, Weber SM, Mingote S, Correa M, Salamone JD. Accumbens dopamine and the regulation of effort in food-seeking behavior: modulation of work output by different ratio or force requirements. Behav Brain Res 2004; 151: 83-91.
74. Aberman JE, Ward SJ, Salamone JD. Effects of dopamine antagonists and accumbens dopamine depletions on time-constrained progressive ratio performance. Pharmacol Biochem Behav 1998; 61: 341-8.
75. Hamill S, Trevitt JT, Nowend KL, Carlson BB, Salamone JD. Nucleus accumbens dopamine depletions and time-constrained progressive ratio performance: Effects of different ratio requirements. Pharmacol Biochem Behav 1999; 64: 21-7.
76. Nowend KL, Arizzi M, Carlson BB, Salamone JD. D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption. Pharmacol Biochem Behav 2001; 69: 373-82.
77. Salamone JD, Arizzi MN, Sandoval MD, Cervone KM, Aberman JE. Dopamine antagonists alter response allocation but do not suppress appetite for food in rats: contrast between the effects of SKF 83566, raclopride, and fenfluramine on a concurrent choice task. Psychopharmacol 2002; 160:371-80.
78. Koch M, Schmid A, Scnhnitzler HU. Role of nucleus accumbens dopamine D1 and D2 receptors in instrumental and Pavlovian paradigms of conditioned reward. Psychopharmacol 2000; 152: 67-73.
79. Cousins MS, Salamone JD. Nucleus accumbens dopamine depletions in rats affect relative response allocation in a novel cost/benefit procedure. Pharmacol Biochem Behav 1994; 49: 85-91.
80. Cousins MS, Atherton A, Turner I, Salamone JD. Nucleus accumbens dopamine depletions alter relative response allocation in a T-maze cost/ benefit task. Behav Brain Res 1996; 74: 189-97.
81. Cousins MS, Salamone JD. Involvement of ventrolateral striatal dopamine in movement initiation and execution: A microdialysis and behavioral investigation. Neuroscience 1996a; 70: 849-59.
82. Cousins MS, Salamone JD. Skilled motor deficits in rats induced by ventrolateral striatal dopamine depletions: behavioral and pharmacological characterization. Brain Res 1996b; 732: 186-94.
83. Mogenson G, Jones D, Yim CY. From motivation to action: Functional interface between the limbic system and the motor system. Progress Neurobiol 1980; 14:69-97.
84. Wyvell CL, Berridge KC. Incentive sensitization by previous amphetamine exposure: increased cue-triggered "wanting" for sucrose reward. J Neurosci 2001; 21: 7831-40.
85. Lopez HH, Ettenberg A. Sexually conditioned incentives: Attenuation of motivational impact during dopamine receptor antagonism. Pharmacol Biochem Behav 2002; 72: 65-72.
86. Sokolowski JD, Conlan AN, Salamone JD. A microdialysis study of nucleus accumbens core and shell dopamine during operant responding in the rat. Neurosci 1998; 86:1001-9.
87. Richardson NR, Gratton A. Behavior-relevant changes in nucleus accumbens dopamine transmission elicited by food reinforcement: an electrochemical study in rat. J Neurosci 1996; 16: 8160-9.
88. Horvitz JC. Dopamine gating of glutamatergic sensorimotor and incentive motivational input signals to the striatum. Behav Brain Res 2002; 137: 65-74.
89. Kiyatkin EA. Dopamine in the nucleus accumbens: Cellular actions, drug- and behavior-associated fluctuations, and a possible role in an organisms' adaptive activity. Behav Brain Res 2002; 137: 27-46.
90. Datla KP, Ahier RG, Young AMJ, Gray JA, Joseph MH. Conditioned appetitive stimulus increases extracellular dopamine in the nucleus accumbens of the rat. Eur J Neurosci 2002; 16: 1987-93.
91. Roitmann MF, Stuber GD, Phillips PD, Wightman RM, Carelli RM. Dopamine operates as a subsecond modulator of food seeking. J Neurosci 2004; 11: 1265-71.
92. Parkinson JA, Dalley JW, Cardinal RN, et al. Nucleus accumbens dopamine depletion impairs both acquisition and performance of appetitive Pavlovian approach behaviour: implications for mesoaccumbens dopamine function. Behav Brain Res 2002; 137:149-63.
93. Wakabayashi KT, Fields HL, Nicola SM. Dissociation of the role of nucleus accumbens dopamine in responding to reward-predictive cues and waiting for reward. Behav. Brain Res 2004; 154: 19-30.
94. Cardinal RN, Everitt BJ. Neural and psychological mechanisms underlying appetitive learning: links to drug addiction. Curr Opin Neurobiol 2004; 14:156-162.
95. Collier GH, Jennings W. Work as a determinant of instrumental performance. J Comp Physiol Psychol 1969; 68: 659-62.
96. Hursh SR, Raslear TG, Shurtleff D, Bauman R, Simmons L. A cost-benefit analysis of demand for food. J Exp Anal Behav 1988; 30: 419-40.
97. Cousins MS, Wei W, Salamone JD. Pharmacological characterization of performance on a concurrent lever pressing/feeding choice procedure: Effects of dopamine antagonist, cholinomimetic, sedative and stimulant drugs. Psychopharmacol 1994; 116: 529-37.
98. Hsiao S, Chen BH. Complex response competition and dopamine blocking: choosing of high cost sucrose solution vs. low cost water in rats. Chin J Physiol 1995; 38: 99-109.
99. Neill DB, Fenton H, Justice JB. Increase in accumbal dopaminergic transmission correlates with response cost not reward of rewarding hypothalamic stimulation. Behav Brain Res 2002; 137: 129-38.
100. Berridge KC. Measuring hedonic impact in animals and infants: microstructure of affective taste reactivity patterns. Neurosci Biobehav Rev 2000; 24: 173-98.
101. Treit D, Berridge KC. A comparison of benzodiazepine, serotonin, and dopamine agents in taste-reactivity paradigm. Pharmacol Biochem Behav 1990; 37: 451-6.
102. Hobbs M, Remington B, Gautier S. Dissociation of wanting and liking for alcohol in humans: a test of incentive-sensitization theory. Psychopharmacology 2005; 178: 493-9.
103. Schmidt K, Nolte-Zenker B, Pazer J, Bauer M, Schmidt G, Heinz A. Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence. Pharmacopsychiat 2001; 34: 66-72.
104. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiat 2003; 160: 13-23.
105. Chevrette J, Stellar JR, Hesse GW, Markou A. Both the shell of the nucleus accumbens and the central nucleus of the amygdala support amphetamine self-administration in the rat. Pharmacol Biochem Behav 2002; 71: 501-7.
106. Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev 1987; 94:469-92.
107. Pohorecky LA. Biphasic action of ethanol. Biobehav Rev 1977; 1: 231-40.
108. Correa M, Miquel M, Sanchis-Segura C, Aragon CMG. Acute lead acetate administration potentiates ethanol-induced locomotor activity in mice: The role of brain catalase. Alcoholism: Clin Exper Res 1999; 23: 799-805.
109. Correa M, Arizzi MN, Betz A, Mingote S, Salamone JD. Locomotor stimulant effects of intraventricular injections of ethanol in rats: acute and repeated administration. Psychopharmacol 2003; 170: 368-75.
110. Correa M, Arizzi MN, Betz A, Mingote S, Salamone JD. Open field locomotor effects in rats after intraventricular injections of ethanol and the ethanol metabolites acetaldehyde and acetate. Brain Res Bull 2003; 62: 197-202.
111. Nadal R, Armario A, Janak PH. Positive relationship between activity in a novel environment and operant ethanol self-administration in rats. Psychopharmacol 2002; 162: 333-8.
112. Marinelli M, Barrot M, Simon H, et al. Pharmacological stimuli decreasing nucleus accumbens dopamine can act as positive reinforcers but have a low addictive potential. Eur J Neurosci 1999; 10: 3269-75
113. Olmstead MC, Parkinson JA, Miles FJ, Everitt BJ, Dickinson A. Cocaine-seeking by rats: regulation, reinforcement and activation. Psychopharmacol 2000; 152: 123-31.
114. Czachowsli CL, Chappell AM, Samson HH. Effects of raclopride in the nucleus accumbens on ethanol seeking and consumption. Alc Clin Exper Res 2001; 25: 1431-40.
115. Vezina P, Lorrain DS, Arnold GM, Austin JD, Suto N. Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J Neurosci 2002; 22: 4654-62.
116. Koob GF, Rocio M, Carrera A, et al. Substance dependence as a compulsive behavior. J Psychopharmacol. 1998; 12: 39-48.
117. Pierce RC, Kalivas PW. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 1997; 25: 192-216.
118. Rushworth MFS, Walton ME, Kennerly SW, Bannerman DM. Action sets and decisions in the medial frontal cortex. Trends Cog Sci 2004; 8: 410-7.
119. Denk F, Walton ME, Jennings KA, Sharp T, Rushworth MFS, Bannerman DM. Differential involvement of serotonin and dopamine systems in cost-benefit decisions about delay or effort. 2005; 179: 587-596.
120. Stahl SM. Symptoms and circuits. Part 1. Major depressive disorder. J Clin Psychiat 2003; 64: 11-12.
121. Stahl SM, Zhang L, Damatarca C, Grady M. Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive function in major depressive disorder. J Clin Psychiat 2003; 64: 6-17.
122. Eljwuegi AS. Central monoamines and their role in major depression. Prog Neuropsychopharm Biol Psychiat 2004; 28: 435-51.
123. Ebert D, Feistel H, Loew T, Pimer A. Dopamine and depression-striatal dopamine D2 receptor SPECT before and after antidepressant therapy. Psychopharmacol 1996; 126: 91-4.
124. Van Praag HM, Korf J. Current developments in the field of antidepressive agents. Ned Tijdschr Geneeskd. 1971; 115:1963-70.
125. Rogers d, Lees AJ, Smith E, Trimble M, Stern GM. Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness: An experimental study. Brain 1987; 110: 761-76.
126. Brown AS, Gershon S. Dopamine and depression. J Neural Trans 1993; 91: 75-109.
127. Flint AJ, Black SE, Campbell-Taylor I, Gailey GF, Levinton C. Abnormal speech articulation, psychomotor retardation, and subcortical dysfunction in major depression. J Psychiat Res 1993; 27: 309-19.
128. Caligiuri MP, Elwanger J. Motor and cognitive aspects of motor retardation in depression. J Affect Dis 2000; 57: 83-93.
129. Volkow ND. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiat 2001; 158: 377-82.
130. Rampello L, Nicoletti G, Raffaele R. Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses. Acta Psychiatr Scand 1991; 84: 552-4.
131. Corcoran C, Wong ML, O'Kean V. Buproprion in the management of apathy. J Psychopharmacol 2004; 18: 133-5.
132. Demyttenaere K, De Fruyt J, Stahl SM. The many faces of fatigue in major depressive disorder. Int J Neuropsychopharm 2005; 8: 93-105.
133. Salamone JD. Antidepressants and placebos: Conceptual problems and research strategies. Prevent Treat 2002; 5: article 24.
134. Bench CJ, Friston KJ, Brown RG, Frackowiak RS, Dolan RJ. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med 1993; 23: 579-90.
135. Brody AL, Saxena S, Mandelkern MA, Fairbanks LA, Ho ML, Baxter LR. Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol Psychiat 2001; 50: 171-8.
136. Brody AL, Barsom MW, Bota RG, Saxena S. Prefrontal-subcortical and limbic circuit mediation of major depressive disorder. Semin Clin Neuropsychiat 2001; 6: 102-12.
137. Hickie I, Ward P, Scott E, et al. Neostriatal rCBF correlates of psychomotor slowing in patients with major depression. Psychiat Res 1999; 20: 75-81.
138. Zahm DS. An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neurosci Biobehav Rev 2000; 24: 85-105.
139. Morgane PJ, Galler JR, Mokler DJ. A review of systems and networks of the limbic forebrain/limbic midbrain. Prog Neurobiol 2005; 75: 143-160.
140. Reis S, Grenyer BF. Pathways to anaclitic and introjective depression. Psychol Psychother 2002; 75: 445-459.
141. Pier MPBI, Hulstijn W, Sabbe BGC. Differential patterns of psychomotor functioning in unmedicated melancholic and nonmelancholic depressed patients. J Psychiat Res 2004; 38: 425-435.
142. Habib M, Athymhormia and disorders of motivation in basal ganglia disease. J Neuropsychiat Clin Neurosci 2004; 16: 509-524.